These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

916 related articles for article (PubMed ID: 15350154)

  • 21. Long acting beta-agonists versus theophylline for maintenance treatment of asthma.
    Wilson AJ; Gibson PG; Coughlan J
    Cochrane Database Syst Rev; 2000; (2):CD001281. PubMed ID: 10796631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events.
    Cates CJ; Jaeschke R; Schmidt S; Ferrer M
    Cochrane Database Syst Rev; 2013 Jun; (6):CD006924. PubMed ID: 23744625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-acting beta2-agonists in asthma: not so SMART?
    Currie GP; Lee DK; Lipworth BJ
    Drug Saf; 2006; 29(8):647-56. PubMed ID: 16872239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Asthma treatment: inhaled beta-agonists.
    Sears MR
    Can Respir J; 1998; 5 Suppl A():54A-9A. PubMed ID: 9753519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adverse effects of beta-agonists: are they clinically relevant?
    Abramson MJ; Walters J; Walters EH
    Am J Respir Med; 2003; 2(4):287-97. PubMed ID: 14719995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
    Ohar JA; Donohue JF
    Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of childhood asthma: how do the available options compare?
    Coghlan D; Powell C
    Paediatr Drugs; 2003; 5(10):685-98. PubMed ID: 14510626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of inhaled formoterol in the treatment of asthma.
    Berger WE
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):24-33. PubMed ID: 16892777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of long-acting beta2-adrenergic agonists in asthma management based on updated asthma guidelines.
    Prenner BM
    Curr Opin Pulm Med; 2008 Jan; 14(1):57-63. PubMed ID: 18043276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of salmeterol xinafoate in the treatment of COPD.
    Mahler DA; Donohue JF; Barbee RA; Goldman MD; Gross NJ; Wisniewski ME; Yancey SW; Zakes BA; Rickard KA; Anderson WH
    Chest; 1999 Apr; 115(4):957-65. PubMed ID: 10208192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-acting beta(2)-agonists in management of childhood asthma: A critical review of the literature.
    Bisgaard H
    Pediatr Pulmonol; 2000 Mar; 29(3):221-34. PubMed ID: 10686044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is a long-acting inhaled bronchodilator the first agent to use in stable chronic obstructive pulmonary disease?
    Tashkin DP
    Curr Opin Pulm Med; 2005 Mar; 11(2):121-8. PubMed ID: 15699783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease.
    Rennard SI; Anderson W; ZuWallack R; Broughton J; Bailey W; Friedman M; Wisniewski M; Rickard K
    Am J Respir Crit Care Med; 2001 Apr; 163(5):1087-92. PubMed ID: 11316640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-acting beta 2 agonists for stable chronic obstructive pulmonary disease.
    Sestini P; Renzoni E; Robinson S; Poole P; Ram FS
    Cochrane Database Syst Rev; 2002; (4):CD001495. PubMed ID: 12519559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. State of the art in beta2-agonist therapy: a safety review of long-acting agents.
    Rabe KF
    Int J Clin Pract; 2003 Oct; 57(8):689-97. PubMed ID: 14627180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of formoterol for the treatment of chronic obstructive pulmonary disease.
    Berger WE; Nadel JA
    Respir Med; 2008 Feb; 102(2):173-88. PubMed ID: 18023995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of inhaled salmeterol and oral zafirlukast in asthmatic patients using concomitant inhaled corticosteroids.
    Nelson HS; Nathan RA; Kalberg C; Yancey SW; Rickard KA
    MedGenMed; 2001 Jul; 3(4):3. PubMed ID: 11549982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. β2-agonist therapy in lung disease.
    Cazzola M; Page CP; Rogliani P; Matera MG
    Am J Respir Crit Care Med; 2013 Apr; 187(7):690-6. PubMed ID: 23348973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL; Baker EL; Coleman CI
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [efficacy and safety of salmeterol in long-term therapy in patients with chronic obstructive airway diseases].
    Beeh KM; Wiewrodt R; Salem AE; Buhl R
    Pneumologie; 2000 Jun; 54(6):225-31. PubMed ID: 10934892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.